Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in CP/CPPS
NCT06159114Phase 4Completed
- Sponsor
- Guiyang Xintian Pharmaceutical Co., Ltd.
- Start
- Dec 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Ningmitai Capsule in chronic prostatitis (CP), chronic pelvic pain syndrome (CPPS), sponsored by Guiyang Xintian Pharmaceutical Co., Ltd.. Started Dec 2023; status: completed.
02
Drugs
Ningmitai Capsule
03
Conditions
chronic prostatitis (CP)chronic pelvic pain syndrome (CPPS)
Beyond the preview
Go deeper on NCT06159114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06159114.